JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caraco, Y.
Right arrow Articles by Wood, A. J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caraco, Y.
Right arrow Articles by Wood, A. J. J.

Vol. 281, Issue 1, 330-336, 1997

Pharmacogenetic Determinants of Codeine Induction by Rifampin: The Impact on Codeine's Respiratory, Psychomotor and Miotic Effects1

Yoseph Caraco2 3 , James Sheller and Alastair J. J. Wood

Division of Clinical Pharmacology (Y.C., A.J.J.W.) and Pulmonary Department (J.S.), Vanderbilt University School of Medicine, Nashville, Tennessee

Our objective was to examine the effect of rifampin on codeine's pharmacodynamics and pharmacokinetics in extensive (EMs) and poor (PMs) metabolizers of debrisoquin. Fifteen healthy, nonsmoking males, 9 EMs and 6 PMs of debrisoquin, received codeine (120 mg) before and after rifampin (600 mg/d) for 3 weeks. The effects of codeine on respiration, pupil diameter and psychomotor performance were measured before codeine administration and during each study day. The pharmacokinetics of codeine were determined from the respective plasma and urine concentrations. Before the administration of rifampin, the pharmacodynamic effects of codeine were more prominent in the EMs (P < .01). Rifampin significantly enhanced codeine oral clearance by increasing its metabolic clearances through N-demethylation and glucuronidation in both phenotypes, but its O-demethylation was induced only in EMs. Relative to base-line values, codeine N-demethylation was induced to a greater extent, resulting in a marked reduction in the plasma concentrations of codeine and codeine metabolites and elevated plasma concentrations of norcodeine, norcodeine-glucuronide, and normorphine. The reduction in morphine plasma concentration was associated in the EMs with a significant attenuation of codeine's respiratory and psychomotor effects, whereas its miotic effect was unaltered. In PMs, codeine's respiratory and psychomotor effects were unaltered by rifampin, but its pupillary effect was reduced. Codeine O-demethylation to produce morphine can be significantly induced by rifampin, but this induction is phenotypically determined. However, because (relative to base-line values) rifampin enhanced codeine N-demethylation more than codeine O-demethylation, morphine plasma concentrations were reduced---and hence codeine's pharmacodynamic effects were attenuated---in EMs of debrisoquin.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J Clin PharmacolHome page
M. A. Boyd, X. Zhang, A. Dorr, K. Ruxrungtham, S. Kolis, K. Nieforth, T. Kinchelow, N. Buss, and I. H. Patel
Lack of Enzyme-Inducing Effect of Rifampicin on the Pharmacokinetics of Enfuvirtide
J. Clin. Pharmacol., December 1, 2003; 43(12): 1382 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis
Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 603 - 662.
[Full Text] [PDF]


Home page
NEJMHome page
C. B. Berde and N. F. Sethna
Analgesics for the Treatment of Pain in Children
N. Engl. J. Med., October 3, 2002; 347(14): 1094 - 1103.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
C. K. Finch, C. R. Chrisman, A. M. Baciewicz, and T. H. Self
Rifampin and Rifabutin Drug Interactions: An Update
Arch Intern Med, May 13, 2002; 162(9): 985 - 992.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. G. Williams, D. J. Hatch, and R. F. Howard
Codeine phosphate in paediatric medicine
Br. J. Anaesth., March 1, 2001; 86(3): 413 - 421.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.